A17T (p.Ala17Thr) variant of LOX (Protein-lysine 6-oxidase)
A17T (p.Ala17Thr) in LOX (Protein-lysine 6-oxidase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.
A17T (p.Ala17Thr) variant details
- p.Ala17Thr
- NCI-TCGA Cosmic COSV5023
- cosmic curated COSV50237
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.329
- REVEL 0.01
- CADD 19.10
- PolyPhen-2 0.00
- SIFT 0.37
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available